Antagonistic effect of orphanin FQ on morphine analgesia in rat brain

Acta Physiologica Sinica

Volumn 49, Issue 3, 1997, Pages 333-338

  Tian, Jin Hua ^a   Xu, Wei ^a   Fang, Yuan ^b   Han, Ji Sheng ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Antisense oligodeoxynucleotide; Morphine analgesia; Opioid receptor like receptor; Orphanin FQ

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; LIGAND; MORPHINE; NOCICEPTIN; OPIATE PEPTIDE; OPIATE RECEPTOR; SODIUM CHLORIDE;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MORPHINE ADDICTION; NOCICEPTION; NONHUMAN; PROTEIN FAMILY; RAT; RECEPTOR UPREGULATION;

ANALGESICS, OPIOID; ANIMALS; BRAIN; INJECTIONS, INTRAVENTRICULAR; MALE; MORPHINE; OLIGONUCLEOTIDES, ANTISENSE; OPIOID PEPTIDES; RATS; RATS, WISTAR; RECEPTORS, OPIOID;

EID: 1842300389     PISSN: 03710874     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Mollereau C, Parmentier M, Mailleux P, et al. ORL1, a novel member of the opioid receptor family, cloning, functional expression and localization. FEBS Lett, 1994, 341: 33-38
2. Reinscheid RK, Nothacker HP, Bourson A, et al. Orphanin FQ: a neuropeptide that activates an opioid-like G protein-coupled receptor. Science, 1995, 270: 792-794
3. Meunier JC, Mollereau C, Toll L, et al. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature, 1995, 377: 532-535
4. Anton B, Fein J, To T, et al. Immunohistochemical localization of ORL-1 in the central nervous system of the rat. J Comp Neurol, 1996, 368: 29-251
5. Mogil JS, Grisel JE, Reienschceid RK, et al. Orphanin FQ blocks opioid actions and precipitates opiate withdrawal. Neuroscience, 1996, 75: 333-337
6. Mogil JS, Grisel JE, Zhang GE, et al. Functional antagonism of μ-, δ- and κ-opioid antinociception by Orphanin FQ. Neurosci Lett, 1996, 214:1-4
7. Melzack R, Wall P. The Challenge of Pain. Penguin Book, Harmondsworth, Middlesex. 1982,447
8. Lewis IW, Cannon JT, Liebeskind JC. Opioid and non-opioid mechanisms of stress analgesia. Science, 1980, 208: 623-625
9. Standifer KM, Chien CC, Wahlestedt C, et al. Selective loss of δ opioid analgesia and binding by antisense oligodeoxynucleotides to a δ opioid receptor. Neuron, 1994, 12: 805-810
10. Adams JU, Chen XH, DeRiel JK, et al. Intracerebroventricular treatment with an antisense oligodeoxynucleotide to κ-opioid receptors inhibited κ-agonist-induced analgesia in rats. Brain Res, 1994, 667: 129-132
11. Zheng RQ, Kemeny DM. Inhibition of gene expression by antisense oligodeoxynucleotides. Clin Exp Immunol, 1995, 100: 380-382
12. 2+ in the SH-SY5Y human neuroblastoma cell line. Br J Pharmacol, 1996, 118: 205-207
13. Vaughan CW, Christie MJ. Increase by the ORL(1) receptor (opioid receptor-like (1)) ligand,nociceptin, of inwardly rectifying K conductance in dorsal raphe nucleus neurones. Br J Pharmacol, 1996, 117: 1609-1611
14. Tian JH, Xu W, Fang Y, et al. Bidirectional modulatory effect of orphanin FQ on morphine-induced analgesia: antagonism in brain and potentiation in spinal cord of the rat. Br J Pharmacol, 1996, 120: 676-680
15. Ren MF, Lu CH, Han JS. Dynorphin-A-(1-13) antagonizes morphine analgesia in the brain and potentiates morphine analgesia in the spinal cord. Peptides, 1985, 6:1015-1020